The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bristol-Myers Squibb Co shares valued at $2,650,480 were sold by Elkins David V on Sep 02 ’25. At $47.33 per share, Elkins David V sold 56,000 shares. The insider’s holdings dropped to 167,379 shares worth approximately $8.93 million following the completion of this transaction.
Also, Elkins David V purchased 56,000 shares, netting a total of over 2,648,800 in proceeds.
Before that, Short Bartie Wendy had sold 378 shares from its account. In a trade valued at $16,719, the EVP, Corporate Affairs traded Bristol-Myers Squibb Co shares for $44.23 each. Upon closing the transaction, the insider’s holdings decreased to 378 shares, worth approximately $0.27 million.
As published in a research note from BofA Securities on December 15, 2025, Bristol-Myers Squibb Co [BMY] has been rated up from a Neutral to a Buy and the price target has been revised to $61. Analysts at Guggenheim upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in mid December. As of November 13, 2025, Scotiabank has initiated its “Sector perform” rating for BMY. Earlier on August 05, 2025, Daiwa Securities downgraded its rating. Their new recommendation was “a Neutral” for BMY stock which previously was a “an Outperform”.
Analyzing BMY Stock Performance
On last trading session, Bristol-Myers Squibb Co [NYSE: BMY] plunged -0.41% to $53.33. The stock’s lowest price that day was $53.092, but it reached a high of $53.8 in the same session. During the last five days, there has been a surge of approximately 4.16%. Over the course of the year, Bristol-Myers Squibb Co shares have dropped approximately -4.55%. Shares of the company reached a 52-week high of $63.33 on 03/11/25 and a 52-week low of $42.52 on 10/29/25.
Support And Resistance Levels for Bristol-Myers Squibb Co (BMY)
According to the 24-hour chart, there is a support level at 53.01, which, if violated, would cause prices to drop to 52.70. In the upper region, resistance lies at 53.72. The next price resistance is at 54.12. RSI (Relative Strength Index) is 66.76 on the 14-day chart, showing neutral technical sentiment.
Is Bristol-Myers Squibb Co subject to short interest?
Stocks of Bristol-Myers Squibb Co saw a sharp rise in short interest on 2025-11-28 jumping by 1.82 million shares to 33.89 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 32.07 million shares. A jump of 5.37% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.12 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.12.
Which companies own the most shares of Bristol-Myers Squibb Co (BMY)?
In terms of Bristol-Myers Squibb Co share price expectations, FactSet research, analysts set an average price target of 53 in the next 12 months, down nearly -1.03% from the previous closing price of $53.55. Analysts anticipate Bristol-Myers Squibb Co stock to reach 65 by 2025, with the lowest price target being 37. In spite of this, 14 analysts ranked Bristol-Myers Squibb Co stock as Hold at the end of 2025.
